title: The elderly liver transplant recipient: a call for caution.
abstract: OBJECTIVE
  To determine whether liver transplantation is judicious in recipients older than 60 years of age.
  
  
  BACKGROUND
  The prevailing opinion among the transplant community remains that elderly recipients of liver allografts fare as well as their younger counterparts, but our results have in some cases been disappointing. This study was undertaken to review the results of liver transplants in the elderly in a large single-center setting. A secondary goal was to define, if possible, factors that could help the clinician in the prudent allocation of the donor liver.
  
  
  METHODS
  A retrospective review of a prospectively maintained single-institution database of 1,446 consecutive liver transplant recipients was conducted. The 241 elderly patients (older than 60 years) were compared with their younger counterparts by preoperative laboratory values, illness severity, nutritional status, and donor age. Survival data were stratified and logistic regression analyses were conducted.
  
  
  RESULTS
  Elderly patients with better-preserved hepatic synthetic function or with lower pretransplant serum bilirubin levels fared as well as younger patients. Elderly patients who had poor hepatic synthetic function or high bilirubin levels or who were admitted to the hospital had much lower survival rates than the sicker younger patients or the less-ill older patients. Recipient age 60 years or older, pretransplant hospital admission, and high bilirubin level were independent risk factors for poorer outcome.
  
  
  CONCLUSIONS
  Low-risk elderly patients fare as well as younger patients after liver transplantation. However, unless results can be improved, high-risk patients older than 60 years should probably not undergo liver transplantation.
authors.affiliation: Baylor University Medical Center, Transplantation Services, Dallas, Texas 75246, USA. mf.levy@baylordallas.edu.
authors.forename: M F
authors.initials: MF
authors.lastname: Levy
authors.forename: P S
authors.initials: PS
authors.lastname: Somasundar
authors.forename: L W
authors.initials: LW
authors.lastname: Jennings
authors.forename: G J
authors.initials: GJ
authors.lastname: Jung
authors.forename: E P
authors.initials: EP
authors.lastname: Molmenti
authors.forename: C G
authors.initials: CG
authors.lastname: Fasola
authors.forename: R M
authors.initials: RM
authors.lastname: Goldstein
authors.forename: T A
authors.initials: TA
authors.lastname: Gonwa
authors.forename: G B
authors.initials: GB
authors.lastname: Klintmalm
mesh_terms: D000367:Age Factors; D000368:Aged; D005260:Female; D006085:Graft Survival; D006801:Humans; D016031:Liver Transplantation / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D012044:Regression Analysis; D012189:Retrospective Studies; D012307:Risk Factors; D016019:Survival Analysis; D016896:Treatment Outcome